博瑞医药(688166.SH)网上路演时间为10月24日14:00-17:00
格隆汇10月22日丨博瑞医药(688166.SH)发布首次公开发行股票并在科创板上市网上路演公告,首次公开发行4100万股,占发行后公司总股本的10.00%,初始战略配售预计发行数量为205万股,占此次发行总数量的5.00%。
回拨机制启动前,网下初始发行数量为3116万股,占扣除初始战略配售数量后发行数量的80.00%;网上初始发行数量为779万股,占扣除初始战略配售数量后发行数量的20.00%。最终网下、网上发行合计数量为此次发行总数量扣除最终战略配售数量,网上最终发行数量及网下最终发行数量将根据回拨情况确定。
为便于投资者了解发行人的有关情况和此次发行的相关安排,发行人和联席主承销商将就此次发行举行网上路演,网上路演时间为2019年10月24日(T-1日)14:00-17:00。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.